Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 16S ribosomal RNA (rRNA) A-site is a critical functional region within the 30S subunit of the bacterial ribosome, responsible for the decoding of genetic information during protein synthesis [1, 8]. It serves as the binding site for aminoacyl-tRNA molecules, where the fidelity of translation is ensured through precise codon-anticodon recognition [10, 15]. This site is the primary target for several classes of potent antibiotics, most notably aminoglycosides and tetracyclines [7, 17]. Aminoglycosides bind to the A-site and induce a conformational change that causes the ribosome to misread mRNA, leading to the production of erroneous, toxic proteins and eventual bacterial cell death [1, 20]. Tetracyclines, on the other hand, physically block the entry of tRNAs into the A-site, thereby halting protein elongation [15, 17]. Resistance to drugs targeting this site often arises through enzymatic modification of the antibiotics or post-transcriptional methylation of the 16S rRNA by methyltransferases, which prevents drug binding [4, 6].
Aminoglycosides bind to the A-site of the 16S rRNA, inducing a conformational change in residues A1492 and A1493 that mimics cognate tRNA binding, leading to mRNA misreading and inhibition of translocation [1, 3, 20]. Tetracyclines bind to the 30S subunit and sterically block the binding of aminoacyl-tRNA to the A-site [7, 17].
14 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 16S ribosomal RNA aminoacyl-tRNA site (16S rRNA A-site) (16S rRNA A-site).